Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499

Sort by:

Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Sciatica (Sciatic Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Sciatica...

April 2021 35 pages

Sclerostin (SOST) - Drugs in Development, 2021

US$ 3,000.00

Sclerostin (SOST) - Drugs in Development, 2021 SUMMARY Sclerostin (SOST) - Drugs in Development, 2021 provides in depth analysis on Sclerostin (SOST) targeted pipeline therapeutics. The report provide...

April 2021 35 pages

Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021 SUMMARY Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Seasonal Allergic Rhinit...

April 2021 40 pages

Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Seasonal Influenza pipelin...

April 2021 105 pages

Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Secondary CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Secondary CNS Lymphoma pipeline landsc...

April 2021 35 pages

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Develo...

April 2021 75 pages

Seizures (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Seizures (Central Nervous System) - Drugs in Development, 2021 SUMMARY Seizures (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Seizures pipeline landscape. The repor...

April 2021 70 pages

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021

US$ 3,000.00

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) - Drugs in Development, 2021 SUMMARY Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin...

April 2021 30 pages

Sepsis (Infectious Disease) - Drugs in Development, 2021

US$ 2,500.00

Sepsis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Sepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Sepsis pipeline landscape. The report provides com...

April 2021 230 pages

Septic Shock (Other Diseases) - Drugs in Development, 2021

US$ 2,000.00

Septic Shock (Other Diseases) - Drugs in Development, 2021 SUMMARY Septic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Septic Shock pipeline landscape. The report pr...

April 2021 50 pages

Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Prote...

April 2021 85 pages

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Prot...

April 2021 40 pages

Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) - Drugs in Developmen...

April 2021 30 pages

Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) - Drugs in Developmen...

April 2021 30 pages

Serine/Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine/Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine/Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY S...

April 2021 35 pages

Serine/Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine/Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine/Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase SIK3 (...

April 2021 35 pages

Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) - Drugs in Development, 2021

US$ 3,000.00

Serine/Threonine Protein Kinase/Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.2...

April 2021 30 pages

Serum Albumin (ALB) - Drugs in Development, 2021

US$ 3,000.00

Serum Albumin (ALB) - Drugs in Development, 2021 SUMMARY Serum Albumin (ALB) - Drugs in Development, 2021 provides in depth analysis on Serum Albumin (ALB) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Severe Combined Immune Deficiency (SCID) (Genetic Disorders) - Drugs in Development, 2021 provides an...

April 2021 35 pages

Sezary Syndrome (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Sezary Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Sezary Syndrome (Oncology) - Drugs in Development, 2021 provides an overview of the Sezary Syndrome pipeline landscape. The report provi...

April 2021 55 pages

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) - Drugs in Development, 2021

US$ 3,000.00

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) - Drugs in Development, 2021 SUMMARY Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or...

April 2021 30 pages

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021

US$ 3,000.00

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021 SUMMARY Signal Transducer And Activator Of Transcript...

April 2021 110 pages

Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021

US$ 3,000.00

Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021 SUMMARY Signal Transducer And Activator Of Transcription 5 (STAT5) - Drugs in Development, 2021 provides in dept...

April 2021 30 pages

Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Simp...

April 2021 70 pages

Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021

US$ 3,000.00

Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 SUMMARY Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 provides in depth analysis on Sirtuin (SIRT or EC 2.3.1.) targeted pipeline th...

April 2021 30 pages

Skin Infections (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Skin Infections (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Infections (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Infections pipeline landscape. The report...

April 2021 45 pages

Skin Inflammation (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Skin Inflammation (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Inflammation (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Inflammation pipeline landscape. The...

April 2021 45 pages

Skin And Skin Structure Infections (SSSI) Caused By Bacteria (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Caused By Bacteria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Skin And Skin Structure Infections (SSSI) Caused By Bacteria (Infectious Disease)...

April 2021 60 pages

Skin And Skin Structure Infections (SSSI) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Skin And Skin Structure Infections (SSSI) (Infectious Disease) - Drugs in Development, 2021 provides...

April 2021 30 pages

Skin And Soft Tissue Infections (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Skin And Soft Tissue Infections (Dermatology) - Drugs in Development, 2021 SUMMARY Skin And Soft Tissue Infections (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin And Soft...

April 2021 45 pages

Skin Ulcers (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Skin Ulcers (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Ulcers (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Ulcers pipeline landscape. The report provides co...

April 2021 30 pages

Sleep Apnea (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Sleep Apnea (Respiratory) - Drugs in Development, 2021 SUMMARY Sleep Apnea (Respiratory) - Drugs in Development, 2021 provides an overview of the Sleep Apnea pipeline landscape. The report provides co...

April 2021 30 pages

Sleep Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Sleep Disorders pipeline...

April 2021 55 pages

Small Intestine Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Small Intestine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Small Intestine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Small Intestine Cancer pipeline landsc...

April 2021 35 pages

Smoking Cessation (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Smoking Cessation (Central Nervous System) - Drugs in Development, 2021 SUMMARY Smoking Cessation (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Smoking Cessation pi...

April 2021 55 pages

Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Social Anxiety Disorder (SAD/Social Phobia) (Central Nervous System) - Drugs in Development, 2...

April 2021 30 pages

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) - Drugs in Development, 2021

US$ 3,000.00

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) - Drugs in Development, 2021 SUMMARY Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated...

April 2021 55 pages

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) - Drugs in Development, 2021

US$ 3,000.00

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) - Drugs in Development, 2021 SUMMARY Sodium Dependent Dopamine Transporter (DA Transporter o...

April 2021 115 pages

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) - Drugs in Development, 2021

US$ 3,000.00

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) - Drugs in Development, 2021 SUMMARY Sodium Dependent Serotonin Transporter (5HT Transpor...

April 2021 115 pages

Sodium/Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) - Drugs in Development, 2021

US$ 3,000.00

Sodium/Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) - Drugs in Development, 2021 SUMMARY Sodium/Glucose Cotransporter 1 (...

April 2021 40 pages

Sodium/Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) - Drugs in Development, 2021

US$ 3,000.00

Sodium/Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) - Drugs in Development, 2021 SUMMARY Sodium/Glucose Cotransporter 2 (L...

April 2021 70 pages

Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Soft Tissue Sarcoma pipeline landscape. The...

April 2021 220 pages

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) - Drugs in Development, 2021

US$ 3,000.00

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) - Drugs in Development, 2021 SUMMARY Sol...

April 2021 35 pages

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021

US$ 3,000.00

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 SUMMARY Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 provides in depth analysis on Somatostatin...

April 2021 40 pages

Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021

US$ 3,000.00

Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021 SUMMARY Somatostatin Receptor Type 5 (SSTR5) - Drugs in Development, 2021 provides in depth analysis on Somatostatin Receptor Type 5 (...

April 2021 45 pages

Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Spasmodic Torticollis (Cervical Dystonia) (Central Nervous System) - Drugs in Development, 2021...

April 2021 30 pages

Sphingosine 1-Phosphate Receptor (S1PR) - Drugs in Development, 2021

US$ 3,000.00

Sphingosine 1-Phosphate Receptor (S1PR) - Drugs in Development, 2021 SUMMARY Sphingosine 1-Phosphate Receptor (S1PR) - Drugs in Development, 2021 provides in depth analysis on Sphingosine 1-Phosphate...

April 2021 35 pages

Spinal Cord Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Spinal Cord Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Spinal Cord Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Spinal Cord...

April 2021 35 pages

Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Spinal Stenosis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Spinal Stenosis pipeline...

April 2021 30 pages

Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Splenic...

April 2021 45 pages

Filters

Clear all